Influence of narrow-band ultraviolet B on serum vitamin D3 for patients with atopic dermatitis
10.3760/cma.j.issn.1671-7368.2015.04.013
- VernacularTitle:窄谱中波紫外线对特应性皮炎患者血清维生素D3水平的影响
- Author:
Zequn MIAO
;
Guifeng XIAO
- Publication Type:Journal Article
- Keywords:
Dermatitis,atopic;
Vitamin D3
- From:
Chinese Journal of General Practitioners
2015;14(4):285-287
- CountryChina
- Language:Chinese
-
Abstract:
To explore the clinical efficacies of narrow-band ultraviolet B (NB-UVB) for atopic dermatitis (AD).Thirty AD patients (observation group) and 30 homochromous healthy volunteers (control group) were compared.The post-treatment scores of Scoring AD (SCORAD) and visual analogue scale (VAS) [(29.4 ± 9.5) & (3.2 ± 1.1) points] were lower significantly those pre-treatment [(60.7 ± 11.4) & 6.3 ± 1.6) points] (P ＜ 0.01).The pre and post-treatment serum levels of 25 (OH) D3 and 1,25 (OH)2D3 were detected with enzyme-linked immunosorbent assay (ELISA).The post-treatment serum levels of 25 (OH) D3 and 1,25 (OH) 2 D3 [(75.36 ± 23.28) mmol/L & (149.28 ± 45.56) nmol/L] were significantly higher than those pre-treatment in observation group [(36.24 ± 18.48) mmol/L & (97.68 ± 32.88)nmol/L] (P ＜0.01).There were no significant differences from those in group control[(69.84 ± 20.64) mmol/L & (147.36 ± 43.68) nmol/L] (P ＞ 0.05).And the pre-treatment serum levels of 25 (OH) D3 and 1,25 (OH)2D3 were all significantly lower in observation group than those in control group (P ＜ 0.01).Thus NB-UVB therapy is both safe and effective for AD and it can boost significantly the serum level of vitamin D3.
